The effectiveness of the anti-PD-L1 treatment in melanoma was boosted when selected gut microbiota were taken orally, because they raised the degree of the tumor-specific T-cell response, the tumor’s infiltration by CTLs, and IFN production. The gene discussed is IFNA1; the disease is neoplasm.